Chemotherapy plus immunotherapy for patients with primary and metastatic brain tumors

R. Knerich, G. Robustelli della Cuna, G. Butti, L. Pavesi, D. Adinolfi, P. Preti, D. Locatelli

Research output: Contribution to journalArticle

Abstract

The authors report two clinical trials concerning chemotherapy and immunotherapy combined in the treatment of primary and metastatic brain tumors. In the first study Bacillus Calmette-Guerin (BCG) and in the second levamisole (LMS) were utilized as immunostimulating agents. Chemotherapy was performed with BCNU and CCNU in association with surgery and/or radiotherapy. An immunological response was obtained but immunotherapy failed to demonstrate any significant effect on survival.

Original languageEnglish
Pages (from-to)19-24
Number of pages6
JournalJournal of Neurosurgical Sciences
Volume29
Issue number1
Publication statusPublished - 1985

    Fingerprint

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Knerich, R., Robustelli della Cuna, G., Butti, G., Pavesi, L., Adinolfi, D., Preti, P., & Locatelli, D. (1985). Chemotherapy plus immunotherapy for patients with primary and metastatic brain tumors. Journal of Neurosurgical Sciences, 29(1), 19-24.